[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
The Senate and House are considering an amendment to the HSS
appropriation that would extend for 5 years the Taxol monopoly, in
exchange for 3 percent of net sales, for biomedical research.
Basically levying a heavy tax on cancer patients to fund more medical
research, which will give given away as more corporate welfare.
James Love | Center for Study of Responsive Law
P.O. Box 19367 | Washington, DC 20036 | http://www.cptech.org
voice 202.387.8030 | fax 202.234.5176 | email@example.com